Cargando…

Using anti-platelet therapy to prevent extracorporeal membrane oxygenator thrombosis without heparin resistance and with thrombocytopenia

Detalles Bibliográficos
Autores principales:	He, Huai-Wu, Zhou, Xiang, Long, Yun, Wang, Xiao-ting, Zhang, Qing, Zhao, Hua, Zhang, Hong-min, Chai, Wen-zhao, Liu, Da-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213460/ https://www.ncbi.nlm.nih.gov/pubmed/25672819 http://dx.doi.org/10.1186/s13054-014-0595-9

Ejemplares similares

Heparin-Induced Thrombocytopenia in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation
por: Lüsebrink, Enzo, et al.
Publicado: (2023)

Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporeal membrane oxygenation
por: Lubnow, Matthias, et al.
Publicado: (2022)

Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study
por: Fisser, Christoph, et al.
Publicado: (2021)

Platelet phosphatidylserine is the critical mediator of thrombosis in heparin-induced thrombocytopenia
por: Zlamal, Jan, et al.
Publicado: (2023)

Commentary: Are platelet patterns repeated in delayed heparin-induced thrombocytopenia/heparin-induced thrombocytopenia and thrombosis syndrome after cardiac surgery?
por: Kramer, Robert S., et al.
Publicado: (2020)

Heparin: Heparin-induced thrombocytopenia and thrombosis: case report
Publicado: (2020)

Heparin: Thrombocytopenia and thrombosis: case report
Publicado: (2021)

Management of Bivalirudin Anticoagulation Therapy for Extracorporeal Membrane Oxygenation in Heparin-Induced Thrombocytopenia: A Case Report and a Systematic Review
por: Zhong, Han, et al.
Publicado: (2020)

Suspected heparin-induced thrombocytopenia in a COVID-19 patient on extracorporeal membrane oxygenation support: a case report
por: Phan, Xuan T., et al.
Publicado: (2020)

Preventing thrombosis in a COVID‐19 patient by combined therapy with nafamostat and heparin during extracorporeal membrane oxygenation
por: Doi, Shunichi, et al.
Publicado: (2020)

Heparin-like effect in postcardiotomy extracorporeal membrane oxygenation patients
por: Ranucci, Marco, et al.
Publicado: (2014)

Extracorporeal Membrane Oxygenation Complications in Heparin- and Bivalirudin-Treated Patients
por: Giuliano, Katherine, et al.
Publicado: (2021)

The interaction of thrombocytopenia, hemorrhage, and platelet transfusion in venoarterial extracorporeal membrane oxygenation: a multicenter observational study
por: Raasveld, Senta Jorinde, et al.
Publicado: (2023)

The Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents
por: Miklosz, Joanna, et al.
Publicado: (2019)

Near fatal stent thrombosis in an aneurysmatic RCX as first manifestation of heparin induced thrombocytopenia (HIT) without thrombocytopenia
por: Zoller, Marc, et al.
Publicado: (2021)

Extracorporeal renal replacement therapy in patients with heparin-induced thrombocytopenia
por: Bekers-Anchipolovskis, M, et al.
Publicado: (2009)

Intra‐cardiac thrombosis in the setting of heparin‐induced thrombocytopenia
por: Mohamed, Amr
Publicado: (2021)

Use of fondaparinux in patients with heparin-induced thrombocytopenia on veno-venous extracorporeal membrane oxygenation: A three-patient case series report
por: Rychlíčková, Jitka, et al.
Publicado: (2023)

Low Molecular Weight Heparin Induced Skin Necrosis without Platelet Fall Revealing Immunoallergic Heparin Induced Thrombocytopenia
por: Godet, Thomas, et al.
Publicado: (2013)

Heparin-induced thrombocytopenia in COVID-19 patients with severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation: two case reports
por: Bidar, Frank, et al.
Publicado: (2020)

Inferior vena cava thrombosis during extracorporeal membrane oxygenation: a case report and review of the literature
por: Chen, YouLian, et al.
Publicado: (2021)

Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation
por: Ranucci, Marco, et al.
Publicado: (2011)

Heparin-induced thrombocytopenia and thrombosis in a patient with Covid-19()
por: Huang, Ching-Tai, et al.
Publicado: (2020)

Heparin: Haemorrhagic complications, deep vein thrombosis and heparin-induced thrombocytopenia: 7 case reports
Publicado: (2021)

Heparin-induced thrombocytopenia in extra-corporeal membrane oxygenation: epidemiology, outcomes, and diagnostic challenges
por: Zaaqoq, Akram M., et al.
Publicado: (2021)

Drug-Immune Thrombocytopenia with Thrombosis versus Heparin-Induced Thrombocytopenia: A Critical Clinical Controversy
por: Al-Jafar, Hassan, et al.
Publicado: (2015)

Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia
por: Tardy, Brigitte, et al.
Publicado: (2020)

Effect of heparin during extracorporeal detoxification in the severity of thrombocytopenia in patients with severe sepsis
por: Kulabukhov, VV, et al.
Publicado: (2012)

STUDIES IN EXPERIMENTAL EXTRACORPOREAL THROMBOSIS : III. EFFECTS OF CERTAIN ANTICOAGULANTS (HEPARIN AND HIRUDIN) ON EXTRACORPOREAL THROMBOSIS AND ON THE MECHANISM OF THROMBUS FORMATION.
por: Shionoya, Takuji
Publicado: (1927)

Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia
por: Perdomo, José, et al.
Publicado: (2019)

Arterial and Venous Thrombosis From Delayed-Onset Heparin-Induced Thrombocytopenia
por: Chittal, Abhinandan R., et al.
Publicado: (2022)

The Appropriateness of Testing Platelet Factor 4/Heparin Antibody in Patients Suspected of Heparin-induced Thrombocytopenia
por: Jindal, Vishal, et al.
Publicado: (2018)

Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia
por: Giles, Jason B., et al.
Publicado: (2022)

Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients
por: Balle, Camilla Mains, et al.
Publicado: (2019)

Detection of Thrombosis in the Extracorporeal Membrane Oxygenation Circuit by Infrasound: Proof of Concept
por: Fuchs, Gabriel, et al.
Publicado: (2016)

Machine learning to predict hemorrhage and thrombosis during extracorporeal membrane oxygenation
por: Abbasi, Adeel, et al.
Publicado: (2020)

Inferior Vena Cava Thrombosis with Veno-arterial Extracorporeal Membrane Oxygenation
por: Takemoto, Kiyoshi, et al.
Publicado: (2022)

Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia
por: Datta, Payel, et al.
Publicado: (2021)

Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?
por: Nguyen, Tung Phi, et al.
Publicado: (2021)

Heparin-free extracorporeal membrane oxygenation in a patient with severe pulmonary contusions and bronchial disruption
por: Ryu, Kyoung Min, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vpn9u1ocehofjfe8s8mb91t3th